Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TRITECH GROUP LIMITED Capital/Financing Update 2025

Oct 30, 2025

67719_rns_2025-10-30_3b993c18-6f37-4680-8130-c45a270955a8.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

TRITECH GROUP LIMITED

(Company Registration No. 200809330R)

(Incorporated in the Republic of Singapore)

  • (A) UPDATE ON THE USE OF PROCEEDS FROM PLACEMENT COMPLETED ON 13 AUGUST 2025

  • (B) PROPOSED PLACEMENT OF UP TO 135,000,000 NEW ORDINARY SHARES IN THE CAPITAL OF THE COMPANY

(A) USE OF PROCEEDS FROM THE PLACEMENT COMPLETED ON 13 AUGUST 2025

1. INTRODUCTION

  • 1.1. The Board refers to the Company’s announcements dated 30 July 2025, 6 August 2025 and 13 August 2025 (collectively, the “ Previous Announcements ”) in relation to the placement of up to 100,000,000 new ordinary shares in the capital of the Company (“ Previous Placement ”).

2. USE OF PROCEEDS FROM THE PREVIOUS PLACEMENT

  • 2.1. Pursuant to the completion of the Previous Placement, the Company raised net proceeds of approximately S$1,025,000, after deducting expenses of approximately S$25,000.

  • 2.2. The Company wishes to provide an update on the use of the net proceeds as follows:

Use of Net Proceeds Allocation of net
proceeds (S$)
Amount utilised as
at the date of this
announcement(S$)
Balance (S$)
Working
capital
including,
inter
alia,
professional fees, staff
salaries and general
overheads
1,025,000 366,000 659,000
Total 1,025,000 366,000 659,000

A breakdown of the net proceeds that were utilised for working capital is as follows:

Summary of expenses Working capital
(S$)
Professional fees 120,000
General overheads 246,000
Total 366,000

2.3. The use of the net proceeds is in accordance with the intended use of proceeds as disclosed in the Previous Announcements. The Board will continue to make periodic announcements on the utilisation of the net proceeds as and when such proceeds are materially disbursed or utilised, and whether such use is in accordance with the stated use of proceeds. The Company will also provide a status report on the use of the net proceeds in its annual report(s) and financial results announcement(s), until such time as the net proceeds have been fully utilised.

(B) THE PROPOSED PLACEMENT

3. INTRODUCTION

  • 3.1. The Board of Directors (the “ Board ” or “ Directors ”) of Tritech Group Limited (the “ Company ” and together with its subsidiaries, the “ Group ”) wishes to announce that the Company had on 30 October 2025 entered into separate placement agreements (collectively, the “ Placement Agreements ”) with the following persons:

  • (a) Lee Sui Hee;

  • (b) Bobby Lim Chye Huat;

  • (c) Tan Hong Seok, Stephanie Lorraine;

  • (d) Ng Tze Kiong; and

  • (e) Yong Kwet Yew,

(collectively, the “ Placees ”, and each, a “ Placee ” and together with the Company, the “ Parties , and each, a “ Party ).

  • 3.2. Pursuant to the Placement Agreements, the Placees have agreed to subscribe for and the Company has agreed to the placement of an aggregate of up to 135,000,000 new ordinary shares (“ Shares ”) in the capital of the Company (the “ Placement Shares ”) at an issue price of S$0.0105 (the “ Issue Price ”) per Placement Share amounting to an aggregate cash consideration of up to S$1,417,500 (the “ Proposed Placement ”).

  • 3.3. The Proposed Placement is not underwritten and will be undertaken pursuant to the exemption under Section 272B of the Securities and Futures Act 2001 of Singapore (“ SFA ”). Accordingly, no prospectus, offer document or offer information statement will be issued by the Company in connection with the Proposed Placement.

4. THE PROPOSED PLACEMENT

4.1. Issue Price

The Issue Price was arrived at following discussions between the Company and the Placees, taking into account, among other things, the prevailing market price of the Shares. The Issue Price represents a premium of approximately 5% to the volume weighted average price of S$0.0100 per Share for trades done on the Catalist of the Singapore Exchange Securities Trading Limited (the “ SGX-ST ”) on 30 October 2025, being the last full market day on which the Shares were traded prior to the entry into the Placement Agreements.

4.2.

Placement Shares

  • 4.2.1. Pursuant to the terms of the Placement Agreements, the Placees shall subscribe for, and the Company shall place an aggregate of up to 135,000,000 Placement Shares at the Issue Price in the following proportions:

2

Name of Placee No. of
Placement
Shares
Consideration
(S$)
Percentage of
Placement
Shares based
on the existing
share capital
of the
Company(1) (%)
Percentage of
Placement
Shares based
on the
enlarged share
capital of the
Company(2) (%)
Lee Sui Hee 40,000,000 420,000 3.12 2.82
Bobby Lim Chye
Huat
20,000,000 210,000 1.56 1.41
Tan Hong Seok,
Stephanie
Lorraine
20,000,000 210,000 1.56 1.41
NgTze Kiong 5,000,000 52,500 0.39 0.35
YongKwet Yew 50,000,000 525,000 3.90 3.53
Total 135,000,000 1,417,500 10.53 9.53

Notes:

  • (1) The percentage shareholding interest is computed based on the existing issued and paid-up share capital (excluding treasury shares and subsidiary holdings) of the Company comprising 1,281,534,398 Shares as at the date of this announcement.

  • (2) The percentage shareholding interest is computed based on the enlarged issued and paid-up share capital (excluding treasury shares and subsidiary holdings) of the Company comprising 1,416,534,398 Shares.

  • (3) Any discrepancies in the figures and the totals thereof are due to rounding. Accordingly, figures shown as totals may not be an arithmetic aggregation of the figures that precede them.

  • 4.2.2. Assuming the successful placement of 135,000,000 Placement Shares, the Placement Shares represent approximately 10.53% of the existing issued and paid-up share capital of the Company comprising 1,281,534,398 Shares (excluding treasury shares and subsidiary holdings) as at the date of this announcement and will represent approximately 9.53% of the enlarged issued and paid-up share capital of the Company of 1,416,534,398 Shares (excluding treasury shares and subsidiary holdings).

  • 4.2.3. The Placement Shares will be issued free from all claims, charges, liens, pledges, mortgages, and other encumbrances whatsoever and shall rank pari passu in all respects with and carry all rights similar to the existing issued Shares, except that they will not rank for any dividend, right, allotment or other distributions, the Record Date (as defined below) for which falls on or before the date of the allotment and issue of the Placement Shares. For the purposes of this paragraph, “ Record Date ” means the date fixed by the Company for the purposes of determining entitlements to dividends or other distributions to or rights of holders of Shares.

  • 4.2.4. The Placement Shares will not be placed to any person who is a Director or a substantial shareholder of the Company as at the date of this announcement, or any other person in the categories set out in Rule 812(1) of the SGX-ST Listing Manual Section B: Rules of Catalist (“ Catalist Rules ”), unless such subscription is otherwise agreed to by the SGX-ST.

  • 4.2.5. The Proposed Placement will not result in any transfer of controlling interest in the Company.

3

4.3. General Mandate

  • 4.3.1. The Placement Shares will be allotted and issued pursuant to the general share issue mandate granted by shareholders of the Company (“ Shareholders ”), by way of an ordinary resolution (“ General Mandate ”) at the annual general meeting of the Company held on 29 July 2025 (“ 2025 AGM ”). The General Mandate authorises the Directors to allot and issue new Shares not exceeding 100% of the total number of issued Shares (excluding treasury shares and subsidiary holdings) as at the date of the 2025 AGM, of which the aggregate number of new Shares of the Company to be issued other than on a pro-rata basis to all existing Shareholders shall not exceed 50% of the total number of issued Shares (excluding treasury shares and subsidiary holdings) as at the date of the 2025 AGM. As at the date of the 2025 AGM, the Company had 1,181,534,398 Shares in issue and accordingly, the Company had 590,767,199 Shares available for issuance under the General Mandate other than on a pro-rata basis.

  • 4.3.2. As at the date of this announcement, under to the General Mandate, the Company had issued 100,000,000 Shares pursuant to a placement exercise completed by the Company on 13 August 2025[1] . Accordingly, up to 490,767,199 new Shares may be issued under the General Mandate other than on a pro-rata basis. Therefore, the proposed allotment and issuance of up to 135,000,000 Placement Shares falls within the limits of the General Mandate.

4.4. Additional Listing Application

The Company will be applying to the SGX-ST, through its sponsor, UOB Kay Hian Private Limited (“ Sponsor ”), for the dealing in, listing of and quotation for the Placement Shares on the Catalist and will make the necessary announcement upon receipt of the listing and quotation notice (“ LQN ”) from the SGX-ST.

5. SALIENT TERMS OF THE PLACEMENT AGREEMENTS

  • 5.1. Placement Completion

Subject to the terms and conditions of the Placement Agreements, completion of the Proposed Placement (“ Completion ”) shall take place no later than seven (7) business days after the date the Company notifies the Placees that the LQN has been obtained from the SGX-ST for the listing of the Placement Shares on the Catalist (“ Completion Date ”), but in any event being a date not later than one (1) month from the date of the Placement Agreements or such other dates as the Parties may agree in writing.

  • 5.2. Conditions Precedent

Under the Placement Agreements, completion of the Proposed Placement is conditional upon the satisfaction or waiver of, inter alia , the following conditions (“ Conditions Precedent ”), on or before such date falling one (1) month from the date of the Placement Agreements (or such date as the Parties may mutually agree):

  • (a) the LQN being obtained from the SGX-ST for the listing and quotation of the Placement Shares on the Catalist and such approval not having been revoked or amended and, where such approval is subject to conditions (which are not normally imposed by the SGX-ST for a transaction of a similar nature), such conditions being acceptable to the Placee and, to the extent that any conditions for such approval are required to be fulfilled on or before the Completion Date, they are so fulfilled;

1 Please refer to the Company’s announcements dated 30 July 2025, 6 August 2025 and 13 August 2025 for further information on the placement exercise.

4

  • (b) the allotment, issue and subscription of the Placement Shares not being prohibited by any statute, order, rule, regulation or directive promulgated or issued after the date of the Placement Agreements by any legislative, executive or regulatory body or authority of Singapore or elsewhere, which is applicable to the Company or the Placees;

  • (c) on the Completion Date, the representations and warranties of the Company under the Placement Agreements being true, accurate and correct in all material respects as if made on the Completion Date, with reference to the then existing circumstances and the Company having performed in all material respects all of its obligations under the Placement Agreements to be performed on or before the Completion Date;

  • (d) there having been, as at the Completion Date, no material adverse change or any development likely to result in a material adverse change, in the condition, financial or otherwise, of the Company and/or any of its subsidiaries from that existing since the date of the Placement Agreements nor any material breach by the Company of any of the obligations, representations, warranties or undertakings, nor has any event occurred, or any fact been discovered, rendering untrue or incorrect in any material respect as at the Completion Date, any of the warranties or undertakings contained in the Placement Agreements if they were repeated on and as of the Completion Date and the Company having performed in all material respects all of its obligations to be performed under the Placement Agreements on or before the Completion Date; and

  • (e) the delivery of a completion certificate by the Company to the Placees on the Completion Date.

5.3. Termination

The respective Placees may at any time prior to or on the Completion Date (after consultation with the Company) by notice to the Company, terminate their respective Placement Agreements, upon the occurrence of any of the following events:

  • (a) if any of the Conditions Precedent has not been satisfied or waived;

  • (b) if there shall come to the notice of the respective Placees any misrepresentation by the Company or if any event occurs or matter arises, which, if it had occurred before the date of the Placement Agreements or before any of the dates or before any time on which the representations, warranties and undertakings are deemed to be given under the Placement Agreements, would have rendered any of those representations, warranties or undertakings, untrue, incorrect, incomplete or misleading in any material respect;

  • (c) if there is a suspension (other than on a temporary basis at the request of the Company) by the SGX-ST of trading of the issued Shares on the Catalist or a delisting of the issued Shares from the Catalist;

  • (d) if there is any introduction of or any change in any statute, regulation, order, policy or directive (whether or not having the force of law and including, without limitation, any directive or request issued by the Monetary Authority of Singapore, the Securities Industry Council or the SGX-ST) or in the interpretation or application thereof by any court or other competent authority;

  • (e) if the SGX-ST shall make any ruling (or revoke any ruling previously made) the effect of which would restrict or impede the listing and quotation of the Placement Shares;

5

  • (f) if the issue and subscription of the Placement Shares in accordance with the provisions of the respective Placement Agreements shall be prohibited by any statute, order, regulation or directive issued by, or objected to by, any legislative, executive or regulatory body or authority of Singapore or elsewhere (including without any limitation, the MAS and the SGX-ST); or

  • (g) if there shall have been or come into effect, since the date of the Placement Agreements:

  • (i) any material adverse change, or any development involving a prospective material adverse change, in the condition (financial or otherwise) of the Company or of the Group as a whole;

  • (ii) any material adverse change, or any development involving a prospective material adverse change, in local, national or international financial, political, industrial, economic or monetary conditions;

  • (iii) any material adverse change, or any development involving a prospective material adverse change, in local, national or international securities or stock markets;

  • (iv) any regional or local outbreak of disease that may have a material adverse effect on the financial markets;

  • (v) any occurrence or any local, national or international outbreak or escalation of hostilities, insurrection or armed conflict; or

  • (vi) any occurrence of any nature whatsoever,

that in the opinion of the respective Placees exercised in good faith, is likely to render the transactions contemplated in the respective Placement Agreements or any of them inadvisable or impracticable to proceed on the terms and in the manner contemplated in the respective Placement Agreements.

6. DISCLOSURES RELATING TO THE PLACEES

  • 6.1. The Placees comprise:

  • (a) Lee Sui Hee, an existing shareholder of the Company;

  • (b) Bobby Lim Chye Huat, a private investor;

  • (c) Tan Hong Seok, Stephanie Lorraine, an existing shareholder of the Company and a director of an associate of the Company;

  • (d) Ng Tze Kiong, a private investor; and

  • (e) Yong Kwet Yew, an existing shareholder of the Company and the Company’s former Non-Executive Chairman and Independent Director.

Each of the Placees was identified through the Company’s network of contacts and has expressed interest in participating in the Proposed Placement for personal investment purposes.

6

  • 6.2. Yong Kwet Yew served as the Non-Executive Chairman and Independent Director of the Company from June 2008 to July 2024. The Company announced on 15 July 2024 that in view of the new requirements that impose hard tenure limits for independent directors, Yong Kwet Yew retired from the Board after serving as Independent Director of the Company for an aggregate period of more than 9 years. Please refer to the Company’s announcement dated 15 July 2025 for further information. As at the date of this announcement, the Company owes Yong Kwet Yew S$525,000 as outstanding director’s fees (“ Outstanding Director’s Fee ”). To demonstrate his confidence in the Company’s prospects and his belief in the future of the Company, Yong Kwet Yew has agreed to participate in the Proposed Placement. Pursuant to the Subscription Agreement entered into with Yong Kwet Yew, the aggregate Issue Price receivable from Yong Kwet Yew shall be set-off against the Outstanding Director’s Fee.

  • 6.3. No placement agent has been appointed in respect of the Proposed Placement. The rationale for the Proposed Placement is for the fundraising purposes as set out in Paragraph 7 below. No introducer fee or commission was paid or is payable in connection with the Proposed Placement.

  • 6.4. As at the date of this announcement, the Placees do not hold, directly or indirectly, any other shares in the Company, except as disclosed in Annex A to this announcement.

  • 6.5. Save as disclosed in this announcement, the Placees (i) are not related to each other; (ii) have no existing connection (including business relationships) with the Company, the Directors and substantial Shareholders; and (iii) are not persons to whom the Company is prohibited from issuing Shares to, as set out under Rule 812 of the Catalist Rules.

  • 6.6. The Placees are subscribing for the Placement Shares as principal and for their own benefit and are not acting in concert with each other, any other person or company, and have not entered into any agreement, arrangement or understanding (whether oral or in writing) with any person or company to act as parties in concert in relation to the Company's Shares, within the definition of the Singapore Code on Take-overs and Mergers.

7. RATIONALE AND USE OF PROCEEDS

  • 7.1. The Proposed Placement will allow the Group to strengthen its financial position by improving liquidity, bolstering its cash reserves and reducing its liabilities. The Net Proceeds (as defined below) from the Proposed Placement, are intended to be primarily used for general working capital purposes, including, but are not limited to, funding day-to-day operations, settling trade and other payables, professional fees, staff-related expenses, and other general overheads.

  • 7.2. While the Company had completed a placement exercise a few months earlier, the Previous Placement was relatively modest in size and provided only limited funding for the Group’s operational and strategic needs. Given the challenging market environment and the current difficulty in attracting new investors or raising substantial amounts of capital in a single tranche, the Company considers it prudent to undertake a further placement at this juncture to strengthen its balance sheet and ensure sufficient financial resources to support ongoing operations and future growth.

7

  • 7.3. In light of the Group’s current working capital needs and the challenging operating environment, marked by economic uncertainty, inflationary pressures, rising operating costs, and competition in the Singapore market, the additional capital is expected to enhance the Group’s financial flexibility and resilience. The Proposed Placement will allow the Group to better position itself to weather near-term market challenges while pursuing strategic opportunities. Accordingly, the Company and the Directors are of the view that the Proposed Placement is beneficial to and in the interest of the Group.

  • 7.4. Assuming the completion of the Proposed Placement, the estimated net cash proceeds (after deducting estimated expenses of approximately S$33,000 and set-off of Outstanding Director’s Fees of S$525,000) will be approximately S$859,500 (“ Net Proceeds ”).

  • 7.5. Pending the deployment of the Net Cash Proceeds, such proceeds may be deposited with banks and/or financial institutions and/or invested in short-term money market instruments and/or marketable securities, and/or used for any other purposes on a short-term basis, as the Directors may, in their absolute discretion, deem fit in the interests of the Company.

  • 7.6. The Company will make periodic announcements on the utilisation of the Net Cash Proceeds as and when such proceeds are materially disbursed and whether such use is in accordance with the use of proceeds as stated in this announcement. Where the Net Cash Proceeds are used for working capital purposes, the Company will disclose a breakdown with specific details on how the Net Cash Proceeds have been applied. Where there is any material deviation from the stated use of the Net Cash Proceeds, the Company will announce the reasons for such deviation. The Company will also provide a status report on the use of Net Cash Proceeds in the Company's periodic financial statements issued under Rule 705 of the Catalist Rules and its annual reports.

8. FINANCIAL EFFECTS OF THE PROPOSED PLACEMENT

  • 8.1. The pro forma financial effects of the Proposed Placement on the Company’s share capital and the Group’s net tangible assets (“ NTA ”) per Share and earnings per Share (“ EPS ”) as set out below are strictly for illustrative purposes and are not indicative of the actual financial position and results of the Group following the completion of the Proposed Placement.

  • 8.2. The pro forma financial effects have been prepared based on the latest audited financial results of the Group for the financial year ended 31 March 2025 (“ FY2025 ”), on the following bases and assumptions:

  • (a) the Proposed Placement of all 135,000,000 Placement Shares at the Issue Price had been completed on 31 March 2025 for the purpose of illustrating the financial effects on the NTA;

  • (b) the Proposed Placement of all 135,000,000 Placement Shares at the Issue Price had been completed on 1 April 2024 for the purpose of illustrating the financial effects on the EPS;

  • (c) the financial effects of the Proposed Placement being calculated on the assumption that the following allotment and issuance of 100,000,000 Shares pursuant to the placement undertaken by the Company and completed on 13 August 2025;

  • (d) the share capital of the Company as at the date of this announcement comprising 1,281,534,398 Shares; and

8

  • (e) the expenses incurred in connection with the Proposed Placement amounting to S$33,000.

8.3. Share capital

Number of Shares (excluding
treasury shares)
As at the date of this announcement 1,281,534,398
After the completion of the Proposed Placement 1,416,534,398

8.4. NTA per Share

Assuming that the Proposed Placement was completed on 31 March 2025, the pro forma financial effects on the Group’s NTA per Share would be as follows:

Before the Proposed
Placement
After the Proposed
Placement
NTA attributable to the owners of
the Company (S$)
(2,541,193) (1,156,693)
Number of issued ordinary
shares in the capital of the
Company
1,281,534,398 1,416,534,398
NTAper Share(Singapore cents) (0.20) (0.08)

8.5. Earnings per Share

Assuming that the Proposed Placement was completed on 1 April 2024, the pro forma financial effects on the Group’s Earnings per Share would be as follows:

Before the Proposed
Placement
After the Proposed
Placement
Earnings
after
income
tax
attributable to the owners of the
Company (S$)
35,489 35,489
Number of issued ordinary shares
in the capital of the Company
1,281,534,398 1,416,534,398
Earnings per Share (Singapore
cents)
0.0028 0.0025

9. DIRECTORS’ OPINION

The Directors are of the opinion that, as at the date of this announcement:

  • (a) after taking into consideration the Group's present internal resources and present bank facilities available to the Group, the Group has sufficient working capital to meet its present requirements. Notwithstanding the above, the Company is undertaking the Proposed Placement for the rationale stated in Paragraph 7 above; and

  • (b) after taking into consideration the Group's present internal resources, present bank facilities available to the Group, and the Net Proceeds, the working capital available to the Group is sufficient to meet its present requirements.

9

10. INTERESTS OF DIRECTORS AND CONTROLLING SHAREHOLDERS

To the best knowledge of the Company, none of the Directors or controlling Shareholder(s) or their associates has any interest, direct or indirect, in the Placees, the Placement Agreements or the Proposed Placement, other than through their respective shareholdings and/or directorships in the Company.

For illustration, the interests of the Directors, substantial shareholders, and the Placees in the share capital of the Company as at the date of this announcement and after completion of the Proposed Placement are set out in Annex A to this announcement.

11. DIRECTOR’S RESPONSIBILITY STATEMENT

The Directors collectively and individually accept full responsibility for the accuracy of the information given in this announcement and confirm after making all reasonable enquiries that, to the best of their knowledge and belief, this announcement constitutes full and true disclosure of all material facts about the Proposed Placement, the Placement Agreements and the Group, and the Directors are not aware of any facts the omission of which would make any statement in this announcement misleading. Where information in this announcement has been extracted from published or otherwise publicly available sources or obtained from a named source, the sole responsibility of the Directors has been to ensure that such information has been accurately and correctly extracted from those sources and/or reproduced in this announcement in its proper form and context.

12. DOCUMENTS AVAILABLE FOR INSPECTION

Copies of the Placement Agreements are available for inspection by Shareholders at the registered office of the Company at 31 Changi South Avenue 2, Tritech Building, Singapore 486478 during normal office hours for three (3) months from the date of this announcement.

13. CAUTION IN TRADING

Shareholders and potential investors are advised to exercise caution in trading their Shares as there is no certainty or assurance as at the date of this announcement that the Proposed Placement will be completed or that no changes will be made to the terms hereof. The Company will make the necessary announcements as and when there are further developments. Shareholders are advised to read this announcement, and any further announcements by the Company carefully. Shareholders should consult their stockbrokers, solicitors or other professional advisors if they have any doubts about the action they should take.

BY ORDER OF THE BOARD

Dr Wang Xiaoning (Jeffrey Wang) Managing Director

30 October 2025

This announcement has been reviewed by the Company’s sponsor, UOB Kay Hian Private Limited (the “ Sponsor ”).

10

This announcement has not been examined or approved by the Singapore Exchange Securities Trading Limited (“ SGX-ST ”) and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Mr. Lance Tan, Senior Vice President, at 83 Clemenceau Avenue #10-01 UE Square, Singapore 239920, telephone (65) 6590 6881.

11

ANNEX A

INTERESTS OF DIRECTORS, SUBSTANTIAL SHAREHOLDERS, AND THE SUBSCRIBERS

Number of Percentage Number of Percentage
Shares as at shareholding as Shares upon shareholding
the date of this
at the date of
completion of upon completion
announcement
this
the allotment of the allotment
announcement and issue of the
and issue of the
(%)(1) Placement Placement
Shares Shares(%)(2)
Directors
Mr. Aw Eng Hai 11,765,000 0.92 11,765,000 0.83
Dr. Wang Xiaoning (Jeffrey
Wang)
120,673,628 9.42 120,673,628 8.52
Mr. Zhou Xinping 6,000 0.0005 6,000 0.0004
Mr. Ong Eng Keang - - - -
Mr. Tan Chade Phang - - - -
Substantial Shareholders
(other than Directors and
the Subscriber)
Protocol Capital W.L.L. 83,333,334 6.50 83,333,334 5.88
Adonis Investment Holdings
Pte Ltd

69,317,985
5.41 69,317,985 4.89
The Placees
Lee Sui Hee 53,310,612 4.16 93,310,612 6.59
Bobby Lim Chye Huat - - 20,000,000 1.41
Tan Hong Seok, Stephanie
Lorraine
37,013,333 2.89 57,013,333 4.02
Ng Tze Kiong - - 5,000,000 0.35
Yong Kwet Yew 11,300,000 0.88 61,300,000 4.33

Notes:

(1) The percentage shareholding interest is computed based on the existing issued and paid-up share capital (excluding treasury shares and subsidiary holdings) of the Company comprising of 1,281,534,398 Shares as at the date of this announcement.

(2) The percentage shareholding interest upon completion of the allotment and issue of 135,000,000 Placement Shares is computed based on the enlarged issued and paid-up share capital (excluding treasury shares and subsidiary holdings) of the Company comprising of 1,416,534,398 Shares.